Our Impact

Part of Benzodiazepine Information Coalition’s (BIC) outreach efforts includes awareness and education via many well-known media outlets and publications, conferences and other awareness events and even researching benzodiazepine and their potential for injury. Members of BIC are frequently contacted for interview or commentary in various projects. BIC also maintains a close working relationship with the large benzodiazepine-affected community, serving as a vital bridge, connecting researchers, journalists and other media outlets with patients willing to share their experiences. If you are conducting research, working on a benzodiazepine story, seeking benzodiazepine patients to interview or have an event we should attend, we can help. Please contact us with details.

Some of the media outlets we have assisted…

Media Outreach

The Benzodiazapine: The Next Opioid? Part One and Part Two

MK Menzodoza KSFR Radio

Medical study links miscarriages to anti-anxiety pills

Emily Baucum NBC San Antonio 

An Interview with Dr. Christy Huff

Erin Stair, M.D., MPH, Causes or Cures Podcast

Video: Guard watched one of inmate’s deadly seizures

Ken Kolker, NBC Wood TV

Safe Prescription Drug Use

Amy Keller, RN, Drugwatch

Xanax withdrawal: 'I was fighting for my life'

Susan Samples, NBC Wood TV

Doctors, Patients Struggle with Benzodiazepine Use

Matt Smith, WebMD.com

Woman says anti-anxiety pills have stolen her life

Emily Baucum, News 4 Troubleshooter, NBC San Antonio

The Rise of the Social Media Doctor

Dana Corriel, M.D., Self

The Deadly Worst Case Scenario for America's Xanax Obsession

Maia Szalavitz, Vice

Seidman: An epidemic — and it’s not opioids

Carrie Seidman, Sarasota Herald Tribune

This Is Why Xanax Is Blowing Up in America

Maia Szalavitz, Vice

Dangers of rising benzo prescriptions raise alarms of next drug crisis

NBC News with Lester Holt

These Pills Could Be Next U.S. Drug Epidemic, Public Health Officials Say

Christine Vestal, Pew Trusts

Talk Radio Europe July 11, 2011

Stacy Pinkerton

Overprescribed Podcast with Dr. Christy Huff

Overprescribed with Mika Pollack

A Quiet Drug Problem Among the Elderly

Paula Span, New York Times

With benzos, a doctor discovers ease of dependency, ordeal of withdrawal

M.J. Tidwell, Daily Hampshire Gazette

Cause-of-death finding bolsters cover-up claim in Fremont County jail inmate’s death

Lance Benzel, The Gazette

Too Many Meds? America’s Love Affair With Prescription Medication

Teresa Carr, Consumer Reports

I Tried to Get Off Ativan

Harriet Brown, Vice

A New Patient-Initiated Coalition Battles Benzos

Allen Frances, M.D., Rehabs.com


Our Research

How Chronic Administration of Benzodiazepines Leads To Unexplained Chronic Illnesses: A Hypothesis

What do hypnotics cost hospitals and healthcare?, Daniel Kripke, M.D.

Position Statement on the Use of Benzodiazepine in Patients Receiving Buprenorphine Treatment, Christy Huff, M.D., A.J. Reid Finlayson, M.D.

Study examines factors that boost suicide risk for doctors, A.J. Reid Finlayson, M.D.

Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit, Daniel F. Kripke, M.D.

Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem, Daniel F. Kripke, M.D.

Social Networking and Benzodiazepine Withdrawal: The Reality of Dependence and Necessity of Support, Catherine Pittman, Ph.D.